Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2004-04-13
2009-11-24
Epps-Smith, Janet L. (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
Reexamination Certificate
active
07622302
ABSTRACT:
New processes for improving the manufacture of clavams e.g. clavulanic acid. Novel DNA sequences and new microorganisms capable of producing increased amounts of clavulanic acid are also disclosed.
REFERENCES:
patent: 4202819 (1980-05-01), Kellett et al.
patent: 2108113 (1995-04-01), None
patent: 0 550549 (1990-09-01), None
patent: 550549 (1987-05-01), None
patent: 53-104796 (1978-09-01), None
patent: WO98/33896 (1998-08-01), None
patent: WO00/03581 (2000-01-01), None
patent: WO01/30977 (2001-05-01), None
patent: WO03/040372 (2003-05-01), None
Tahlan et al. (Antimicrobial Agents and Chemotherapy, Mar. 2004; 48(3): 930-939).
Liras P., et al., “Clavulanic acid, a β-lactamase inhibitor: biosynthesis and molecular genetics,”Applied Microbiology and Biotechnology, Springer Verlag Berlin, Germany (2000) 54(4):467-475.
Mosher R., et al., “Genes Specific for the Biosynthesis of Clavam Metabolites Antipodal to Clavulanic Acid are Clustered with the Gene for Clavaminate Synthase 1 inStreptomyces clavuligerus,” Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, DC (May 1999) 43(5):1215-1224.
A.L. Demain, “Biosynthesis and Regulation of Beta-Lactam Antibiotics”,50 Years of Penicillin Applications, History&Trends(1990).
Townsend, et al., “Biosynthesis of clavulanic Acid: Origin of the C3Unit,”J. Am. Chem. Soc., 107(4):1066-1068 (1985).
Valentine, et al., “Evidence that Arginine is a Later Metabolic Intermediate than Ornithine in the Biosyntheis of Clavulanic Acid byStreptomyces clavuligerus,” J. Chem. Soc. Chem. Comm., 15:1210-1211 (1993).
Janc, et al., “Emerging Evidence for a Shared Biosynthetic Pathway Among Clavulanic Acid and the Structurally Diverse Clavam Metabolites,”Bioorg. Med. Chem. Lett., 3:2313-2316 (1993).
Rohl, et al., “Biological properties and mode of action of clavams,”Arch. Microbiol., 147:315-320 (1987).
Aidoo, et al., “Cloning, sequencing and disruption of a gene fromStreptomyces clavuligerusinvolved in clavulanic acid biosynthesis,”Gene, 147:41-46 (1994).
Sambrook, et al.,Molecular Cloning: A Laboratory Manual, 2nd Edition. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
“Postassium Clavulanate,”British Pharmacopoeia(1993); Addendum (1994) pp. 1362-1363.
“Clavulanate Potassium,”British Pharmacopoeia Official Monographs, USP23 NF18 pp. 384-385 (1985).
Hopwood, et al.,Genetic Manipulation of Streptomyces. A Cloning Manual(1985).
Stahl, et al., “Development and Application of Nucleic Acid Probes,”Nucleic Acid Techniques in Bacterial Systematics. Ed. E. Stackebrandt & M. Goodfellow. Toronto: John Wiley & Sons, pp. 204-248 (1991).
Doran, et al., “Isolation and Characterization of a β-Lactamase-Inhibitory Protein fromStreptomyces clavuligerusand Cloning and Analysis of the Corresponding Gene,”J. Bacteriol. 172(9):4909-4918 (1990).
Vieira, et al., “Production of Single-Stranded Plasmid DNA,”Methods Enzymol., 153: 3-11 (1987).
Sanger, et al., “DNA Sequencing with Chain-terminating Inhibitors,”Proc. Natl. Acad. Sci. USA, 74: 5463-5467 (1977).
Ward, et al., “Construction and Characterisation of a Series of Multi-Copy Promoter-Probe Plasmid Vectors forStreptomycesUsing the Aminoglycoside Phosphotransferase Gene fro Tn5 as Indicator,”Mol. Gen. Genet. 203: 468-478 (1986).
Pruess, et al.,“A New Clavam Antibiotic fromStreptomyces clavuligerus,” Journal of Antibiotics, XXXVI(3): 208-212 (Mar. 1983).
Paradkar, et al., “Functional analysis of the Gene Encoding the Clavaminate Synthase 2 Isoenzyme Involved in Clavulanic Acid Biosynthesis inStreptomyces clavuligerus,” Journal of Bacteriology, 177: 1307-1314 (1995).
Hodgson, J.E. et al., “Clavulanic Acid Biosynthesis inStreptomyces clavuligerus: Gene Cloning and Characterization,”Gene, (1995) vol. 166, pp. 49-55.
Busby, R.W., “Expression and Purification of Two Isozymes of Clavaminate Synthase and Initial Characterization of the Iron Binding Site,”J. Biological Chem., (1995), vol. 270(9), pp. 4262-4269.
Brown, D. et al., “Structures of Three Novel β-lactams Isolated fromStreptomyces clavuligerus,” J.C.S. Chem. Comm., (1979), pp. 282-283.
Marsh, E.N. et al., “Two Isozymes of Clavaminate Synthase Central to Clavulanic Acid Formation: Cloning and Sequencing of Both Genes fromStreptomycs clavuligerus,” Biochemistry, (1992), vol. 31, pp. 12648-12657.
Elson, et al., “Studies on the Biosynthesis of Clavulanic Acid.”J. Antibiotics, XXXI(6): 568 (1978).
Evans, R. H. et al., “Ro 22-5417, A New Clavam Antibiotic fromStreptomyces clavuligerusII. Fermentation, Isolation and Structure”J. Antiobiotics, (1983), vol. 36(3), pp. 213-216.
Muller, J-C. et al, “Ro 22-5417, A New Clavam Antibiotic fromStreptomyces clavuligerusIII Absolute Stereochemistry,”J. Antiobiotics, (1983), vol. 36(3), pp. 216-224.
King, H.D. et al., “Clavamycins, New Clavam Antibiotics from Two Variants ofStreptomyces hygroscopicusI. Taxonomy of the Producing Organisms, Germentation, and Biological Activities,”J. Antiobiotics, (1986), vol. 39(4), pp. 510-515.
Janc, J.W. et al., “Purification and Characterizatgion of Clavaminate Synthase fromStreptomyces antibioticus,” J. Biological Chem., (1995), vol. 270(10), pp. 5399-5404.
Iwata-Reuly, D. and C. A. Townsend, “Common Origin of Clavulanic Acid and Other Clavam Metabolites inStreptomyces,” J. Am. Chem. Soc., (1992), vol. 114, pp. 2762-2763.
Paradkar, A. S. and S. E. Jensen, “Functional Analysis of the Gene Encoding the Clavaminate Synthase 2 Isoenzyme Involved in Clavulanic Acid Biosynthesis inStreptomyces clavuligerus,” J. Bacteriology, (1995), vol. 177(5), pp. 1307-1314.
Baldwin, J. E. et al., “Enzymes of Valcalavam Biosynthesis,”Tetrahedron Letters, (1994), vol. 35(17), pp. 2783-2786.
Egan, L.A. et al., “Probable Role of Clavaminic Acid as the Terminal Intermediate in the Common Pathway to Clavulanic Acid and the Antipodal Clavam Metabolites,”J. Am. Chem. Soc., (1997), vol. 119, pp. 2348-2355.
Barton Barry
Griffin Alison Michelle
Jensen Susan
Wong Annie
Epps-Smith Janet L.
Glaxo Group Limited
Han William T.
Knowles Sherry M.
Lockenour Andrea V.
LandOfFree
Process for improving the manufacture of clavams e.g.... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for improving the manufacture of clavams e.g...., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for improving the manufacture of clavams e.g.... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4103808